Aktie A14RN1 AUSTAR LIFESCIENCES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Austar Lifesciences Limited

Aktien

A14RN1

KYG0632L1023

6118

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:05 31.05.2024 		% 5 Tage % 1. Jan.
0,82 HKD -4,65 % Intraday Chart für Austar Lifesciences Limited +2,50 % -47,44 %
26.03. Austar Lifesciences Limited meldet die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
22.01. Austar Lifesciences wird in die Verlustzone rutschen; Aktien fallen MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Austar Lifesciences to Swing to Loss; Shares Drop
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
Austar Lifesciences Hires New Auditor
Austar Lifesciences Swings to Loss in H1
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2023
ValGenesis, Inc. and AUSTAR Group Partner to Deploy Digital, Risk-Based Solutions for Life Sciences Companies in China
Austar Lifesciences Expects Higher Loss in H1
Austar Lifesciences Limited Updates Consolidated Group Earnings Guidance for the Six Months Ending June 30, 2023
Austar Lifesciences Warns of H1 Loss
Austar Lifesciences Limited Provides Group Earnings Guidance for the Six Months Ending 30 June 2023
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Austar Lifesciences Expects 2022 Profit to Fall to 50 Million Yuan
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022
Austar Lifesciences Limited Announces Executive Changes
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Austar Lifesciences Forecasts H1 Profit Fall to $6.4 Million
Austar Lifesciences Limited acquired an unknown minority interest in Noozle Fluid Technology Co., Ltd..
Austar Lifesciences Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14RN1 Aktie
  4. Nachrichten Austar Lifesciences Limited
  5. Andere Sprachen